Exploring BNT162b2 vaccine effectiveness against COVID-19 among pediatric and adolescent population of Qatar

Science Instruments in laboratory room. Science Research Concept.

Researchers evaluated Pfizer-BioNTech’s BNT162b2 messenger ribonucleic acid (mRNA) vaccine effectiveness (VE) against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infections among the pediatric and adolescent population of Qatar.

How fish took over the chilly waters of the deep sea

Previous article

Twitter’s mass layoffs have come. The social platform will never be the same.

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News